Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice.

Dumonteil E, Escobedo-Ortegon J, Reyes-Rodriguez N, Arjona-Torres A, Ramirez-Sierra MJ.

Infect Immun. 2004 Jan;72(1):46-53.

2.

Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease.

Sánchez-Valdéz FJ, Pérez Brandán C, Ferreira A, Basombrío MÁ.

Expert Rev Vaccines. 2015 May;14(5):681-97. doi: 10.1586/14760584.2015.989989. Epub 2014 Dec 11. Review.

PMID:
25496192
3.

Trans-sialidase delivered as a naked DNA vaccine elicits an immunological response similar to a Trypanosoma cruzi infection.

Costa F, Pereira-Chioccola VL, Ribeirão M, Schenkman S, Rodrigues MM.

Braz J Med Biol Res. 1999 Feb;32(2):235-9. Review.

PMID:
10347760
4.

Vaccine development against Trypanosoma cruzi and Chagas disease.

Vázquez-Chagoyán JC, Gupta S, Garg NJ.

Adv Parasitol. 2011;75:121-46. doi: 10.1016/B978-0-12-385863-4.00006-X. Review.

PMID:
21820554
5.

Advances and challenges towards a vaccine against Chagas disease.

Quijano-Hernandez I, Dumonteil E.

Hum Vaccin. 2011 Nov;7(11):1184-91. doi: 10.4161/hv.7.11.17016. Epub 2011 Nov 1. Review.

6.

Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease.

DosReis GA.

Braz J Med Biol Res. 2011 Feb;44(2):84-90. Epub 2011 Jan 14. Review.

7.

Chagas' disease: an update on immune mechanisms and therapeutic strategies.

Boscardin SB, Torrecilhas AC, Manarin R, Revelli S, Rey EG, Tonelli RR, Silber AM.

J Cell Mol Med. 2010 Jun;14(6B):1373-84. doi: 10.1111/j.1582-4934.2010.01007.x. Epub 2010 Jan 11. Review.

8.

Aspects of Trypanosoma cruzi stage differentiation.

Goldenberg S, Avila AR.

Adv Parasitol. 2011;75:285-305. doi: 10.1016/B978-0-12-385863-4.00013-7. Review.

PMID:
21820561
9.

Prophylactic and therapeutic DNA vaccines against Chagas disease.

Arce-Fonseca M, Rios-Castro M, Carrillo-Sánchez Sdel C, Martínez-Cruz M, Rodríguez-Morales O.

Parasit Vectors. 2015 Feb 24;8:121. doi: 10.1186/s13071-015-0738-0. Review.

10.

Experimental Vaccines against Chagas Disease: A Journey through History.

Rodríguez-Morales O, Monteón-Padilla V, Carrillo-Sánchez SC, Rios-Castro M, Martínez-Cruz M, Carabarin-Lima A, Arce-Fonseca M.

J Immunol Res. 2015;2015:489758. doi: 10.1155/2015/489758. Epub 2015 May 18. Review.

11.

Molecular mechanisms of myocarditis caused by Trypanosoma cruzi.

Esper L, Talvani A, Pimentel P, Teixeira MM, Machado FS.

Curr Opin Infect Dis. 2015 Jun;28(3):246-52. doi: 10.1097/QCO.0000000000000157. Review.

PMID:
25887609
12.

Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects.

Dumonteil E, Bottazzi ME, Zhan B, Heffernan MJ, Jones K, Valenzuela JG, Kamhawi S, Ortega J, Rosales SP, Lee BY, Bacon KM, Fleischer B, Slingsby BT, Cravioto MB, Tapia-Conyer R, Hotez PJ.

Expert Rev Vaccines. 2012 Sep;11(9):1043-55. doi: 10.1586/erv.12.85. Review.

13.

Tropical diseases encountered in Canada: 1. Chagas' disease.

Schipper H, McClarty BM, McRuer KE, Nash RA, Penney CJ.

Can Med Assoc J. 1980 Jan 26;122(2):165-9, 171-2. Review.

14.

Reactivation of Chagas Disease: Implications for Global Health.

Perez CJ, Lymbery AJ, Thompson RC.

Trends Parasitol. 2015 Nov;31(11):595-603. doi: 10.1016/j.pt.2015.06.006. Epub 2015 Oct 11. Review.

PMID:
26458782
15.

Cell-based therapy in Chagas disease.

de Carvalho AC, Carvalho AB, Goldenberg RC.

Adv Parasitol. 2011;75:49-63. doi: 10.1016/B978-0-12-385863-4.00003-4. Review.

PMID:
21820551
16.

Development of DNA vaccines as an anti-hypertensive therapy or for anti-angiogenesis.

Nakagami H, Morishita R.

Expert Opin Biol Ther. 2015 Mar;15(3):431-6. doi: 10.1517/14712598.2015.1014791. Epub 2015 Feb 11. Review.

PMID:
25673364

Supplemental Content

Support Center